Enhanced Apoptosis and Tumor Growth Suppression Elicited by Combination of MEK (Selumetinib) and mTOR Kinase Inhibitors (AZD8055)Sarah V. Holt, Paul D. Smith, Armelle Logié et al.|Cancer Research|2012Cited by 86
Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinomaLiyan Jiang, Jiaqi Huang, Wei Zhu et al.|BMC Cancer|2014Cited by 32
Abstract 2398: Activity of the PARP inhibitor olaparib in ATM-deficient gastric cancer: from preclinical models to the clinicDarren Hodgson, Mark J. O’Connor, Brian Dougherty et al.|Cancer Research|2014Cited by 7
Abstract 4909: Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinomaJiaqi Huang, Yihong Yao, Wei Zhu et al.|Cancer Research|2015Cited by 0